In the BioHarmony Drug Report Database
Amoxapine
Asendin, Adasuve (amoxapine) is a small molecule pharmaceutical. Amoxapine was first approved as Asendin on 1982-01-01. It is used to treat depressive disorder, psychophysiologic disorders, and psychotic affective disorders in the USA. It has been approved in Europe to treat bipolar disorder and schizophrenia. The pharmaceutical is active against sodium-dependent serotonin transporter and sodium-dependent noradrenaline transporter. In addition, it is known to target 5-hydroxytryptamine receptor 6, 5-hydroxytryptamine receptor 2C, 5-hydroxytryptamine receptor 7, and 5-hydroxytryptamine receptor 2A.
Trade Name
|
Adasuve |
|---|---|
Common Name
|
amoxapine |
ChEMBL ID
|
CHEMBL1113 |
Indication
|
bipolar disorder, depressive disorder, psychophysiologic disorders, psychotic affective disorders, schizophrenia |
Drug Class
|
Tricyclic compounds |
Image (chem structure or protein)